Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

Expression of lipid biosynthetic genes is decreased with polyamine depletion. by Yazmin E. Cruz-Pulido (20285238)

Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

Anti-SjLLPi1 antibody treatment decreases worm burden in mice 7 days after <i>S. japonicum</i> infection. by Fanyan Chen (3909178)

SP-forming activity of CM precipitated by 80% saturated ammonium sulfate. by Hiroko Kawai-Toyooka (382362)

Subjects:

Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

Map of Pakistan with marked Punjab province. by Sumaira Sumaira (21453523)

PRRSV enters MARC-145 cells via macropinocytosis and rottlerin blocks the macropinocytosis by decreasing actin polymerization. by Yeonglim Kang (21395261)

Subjects:

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). by Elizabeth S. Munroe (21568166)

Evolutionary transitions of gamete dimorphism and gametogenesis induction cues in volvocine algae. by Hiroko Kawai-Toyooka (382362)

Subjects:

Synchronization of the vegetative cycle and SP formation in <i>Eudorina.</i> by Hiroko Kawai-Toyooka (382362)

Subjects:

Effect of pronase pretreatment of male CM on SP formation. by Hiroko Kawai-Toyooka (382362)

Subjects:

Time course of CM-induced SP formation efficiency during colony development of <i>Eudorina.</i> by Hiroko Kawai-Toyooka (382362)

Subjects:

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... by Elizabeth S. Munroe (21568166)

Overview of the six original ACTIV-3/TICO trials. by Elizabeth S. Munroe (21568166)

“…</p><p>Conclusions</p><p>In patients hospitalized with COVID-19, treatment with nMAbs did not decrease long-term anti-nucleocapsid response compared to placebo, suggesting neutralizing therapies do not suppress the endogenous humoral immune response in this population.…”

After 8 weeks of treatment, body fat analysis and bone mineral density testing of mice in each group. by Xueqin lu (22250795)

ECE treatment decreases coronavirus production in the cells. by Siyun Lee (17087351)

Group-level narrow- and broad-band spectral changes after hemispherotomy reveal a marked EEG slowing of the isolated cortex, robust across patients. by Michele Angelo Colombo (22446342)

Even log summary: A) Start and end of each activity, B) Timeline of the activities, C) Identification of outliers using Z-score, e) Analysis of cases taking more than 14 days to co... by Mohammad Bakhtiari (11838264)